HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic value of health-related quality-of-life parameters in early-stage breast cancer: an 8-year follow-up study.

AbstractOBJECTIVE:
The purpose was to investigate whether self-reported health-related quality-of-life (HRQOL) parameters at time of diagnosis and/or 1-year follow-up are prognostic for disease-free survival (DFS) in early-stage breast cancer patients.
METHODS:
Data from 195 women, diagnosed with early-stage breast cancer, who had filled in the EORTC QLQ-C30 and the Hospital Anxiety and Depression Scale (HADS) at time of diagnosis and 1 year after surgery, were analyzed.
RESULTS:
After a median follow-up of 8.2 years (range 0.09-9.45), 27 (14.1%) deaths and 22 (11.5%) recurrences were observed. Using Cox multivariate regression analysis, appetite loss reported 1-year following surgery (HR 2.92, 95% CI 1.50-5.66), p=0.002) was significantly predictive for shorter DFS, even after controlling for age and depression. None of the clinical or biological prognostic factors was found to have a confounding effect.
CONCLUSION:
The findings indicate that loss of appetite probably is of prognostic value in addition to well-recognized clinical and biological data, in early-stage breast cancer.
AuthorsInger Schou Bredal, Leiv Sandvik, Rolf Karesen, Oivind Ekeberg
JournalPsycho-oncology (Psychooncology) Vol. 20 Issue 10 Pg. 1102-7 (Oct 2011) ISSN: 1099-1611 [Electronic] England
PMID20737644 (Publication Type: Journal Article)
Copyright2010 John Wiley & Sons, Ltd.
Topics
  • Adult
  • Age Factors
  • Aged
  • Appetite
  • Breast Neoplasms (diagnosis, mortality, psychology)
  • Depression (etiology, psychology)
  • Female
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Multivariate Analysis
  • Prognosis
  • Proportional Hazards Models
  • Psychiatric Status Rating Scales
  • Quality of Life (psychology)
  • Regression Analysis
  • Survival Analysis
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: